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the CC BY-NC-ND license (http://creaAbstract Objective: Calcium oxalate crystals are found in majority of kidney stones with cal-
cium oxalate monohydrate (COM) as one of the primary types of kidney stones. Various
methods of treatment exist, including herbal treatment in the Philippines that uses the medic-
inal herb Blumea balsamifera (B. balsamifera).
Methods: The effect of B. balsamifera extract on the morphology of calcium oxalate crystals
was studied by light microscopy, image analysis, powder X-ray diffraction and scanning elec-
tron microscopy.
Results: The extract decreased the crystal size by 5.22%e82.62% depending on the degree of
supersaturation. Through analysis of the projected area of the crystals, the extract was found
to shift the phase of the crystals from COM to calcium oxalate dihydrate (COD). This shift in
phase is significant with a COM to COD shift of 88.26% at 0.5 mg/mL of extract and 91.53%
at 1.0 mg/mL of extract. SEM images revealed aggregation of crystals at 0 mg extract/mL.
At 1.0 mg extract/mL, the scanning electron micrographs showed discernible crystal unit
boundaries.
Conclusion: B. balsamifera extract was observed to have decreased crystal size, shifted crys-
tal phase from COM to COD and prevented the aggregation of calcium oxalate crystals.
ª 2016 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).ealegre@coe.upd.edu.ph (C.M. Montealegre).
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Kidney stones have always been a prevalent health problem
facing mankind. Kidney stones are made up of biomolecules
such as antibodies and proteins, minerals such as calcium
oxalate monohydrate (COM, CaC2O4 $ H2O), calcium oxalate
dihydrate (COD, CaC2O4 $ 2H2O), calcium phosphate, stru-
vite (MgNH4PO4 $ 6H2O) and uric acid [1e3]. Some kidney
stones are made of cysteine, but the most pathologically
prevalent are COM stones. An analysis of kidney stone cases
found COM in 99% of extracted stones [1], and in 68% of the
cases, COM was identified as the main stone component [4].
The hydrates of calcium oxalate have been found to exhibit
distinct crystalline structures depending on their degree of
hydration. The monohydrate phase (COM) has a crystalline
structure of elongated rhombohedron units. It has a distinct
hexagonal projection along its 010 face [5e7]. Various
studies showed that the dihydrate phase (COD) has an
octahedral or square-bipyramid structure with a distinct
square projection [5,8,9].
The growth of COM crystals is influenced by the presence
of growth modifiers that have a wide nature from inorganic
compounds, to biologically-produced and synthetic organic
compounds. Some studies explored the growth modifying
properties of herbal treatment to urinary calculi. The
extract of Khella plant was found to influence the crystal-
lization process. In the presence of the extract, more COD
than COM crystals are formed relative to the control [5]. A
mallorcan herbal preparation containing extracts and
tinctures of Zea mays, bearberry, Sabal serrulata and
others, reduced the calcium deposition in renal tissue of
ethylene glycol gavaged rats [10]. Polysaccharide-based
biopolymers such as gum arabic were also shown to
stabilize the formation of COD with a tetragonal bipyramid
or octahedral morphology [11].
Bergenia ciliata rhizome extract was found to decrease
the absorbance of crystallizing solutions with artificial
urine. Based on this decrease in absorbance with the con-
trol solution, a dose dependent inhibition of 58%e97% was
reported [12]. COM and COD crystals were also found to
decrease, however this was solely based on the qualitative
appraisal of the crystal micrographs and lacked quantifi-
cation. These effects were attributed to the polyphenolics
in the extract such as saponins, alkaloids, flavonoids and
terpenoids. Studies involving the crystal growth inhibition
of plant extracts are limited, yet treatment had been in
existence for thousands of years and was even mentioned in
ancient Egyptian texts [13].
A decoction of the leaves of Blumea balsamifera (B.
balsamifera) is reported to have anti-lithogenic effects and
is a means of treating kidney stones. This therapeutic ef-
fect was attributed to the diuretic effect of B. balsamifera
[14], but based on the study of Rodgers et al. [15] it could
not be concluded that the therapeutic effect is merely
based on this property. More so, B. balsamifera contains
several compounds which could have an inhibitory effect on
COM stone formation.
How B. balsamifera influences the crystallization pro-
cess of calcium oxalate has not been fully explored. This
study aims to fill part of that knowledge gap by investi-
gating the effect of B. balsamifera extract on the phasePlease cite this article in press as: Montealegre CM, De Leon RL, Effec
calcium oxalate crystals, Asian Journal of Urology (2016), http://dx.dand morphology of calcium oxalate crystals formed from
supersaturated calcium ion and oxalate ion solutions.
2. Materials and methods
The effect of B. balsamifera extract on the morphology of
calcium oxalate crystals was investigated through light
microscopy, image analysis, powder X-ray diffraction and
scanning electron microscopy. All solutions used throughout
the experiment were prepared with deionized water.
2.1. Extract preparation
The extract of B. balsamifera was prepared from a decoc-
tion of commercially available Golden Spoon (Seamaxx
Enterprises, Manila, Philippines) organic plants all natural
sambong tea. The product processed by Seamaxx Enter-
prises (Manila, Philippines) claims to be made of pure
handpicked B. balsamifera leaves. The leaves were boiled
in deionized water for 5 min. The liquid part was filtered
with a cellulose filter paper and transferred to a volumetric
flask. Repeated washings of boiling deionized water was
used until a clear liquid was achieved. The decoction was
cooled prior to final adjustment of the volume. A fresh
decoction with a concentration of 5 mg dried leaves per mL
solution was prepared prior to its application. Different
concentrations of the extract were prepared from the
freshly prepared decoction. The required amount of
extract was mixed with crystallization solutions and diluted
with deionized water to final volume.
2.2. Light microscopy
Crystals were grown by reactive precipitation of calcium
chloride and sodium oxalate solutions in single-use poly-
propylene cuvettes. These are stored for 72 h at room
temperature to reach equilibrium. The contents of the
cuvette were then stirred, a sample was gathered and
mounted in a hemocytometer and observed under a light
microscope. Micrographs were taken and the images were
subject to image analysis by ImageJ v 1.47t (https://
imagej.nih.gov/ij/download.html) to measure the crystal
size. Shape was quantified by using the ratio between the
maximum Feret diameter and minimum Feret diameter.
2.3. Powder X-ray diffraction and scanning electron
microscopy
Crystals were prepared by bulk crystallization. Required
amounts of water, extract, sodium oxalate solution, and
calcium chloride solution were then mixed. The solution was
covered with a film and left undisturbed for 3 days. Crystals
were harvested by centrifugation at 2504g for 30 min. The
supernatant was discarded and the crystals were dried in a
desiccator for 3 days. The dried crystals were sealed and
maintained in the desiccator prior to analyses.
Samples were analyzed by powder X-ray diffraction
using Rigaku Miniflex II and Hitachi S3400N Scanning Elec-
tron Microscope (SEM). Magnification and electron beam
voltage were adjusted accordingly.124
t of Blumea balsamifera extract on the phase and morphology of
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Fig. 2 The micrograph at a supersaturation of 20.0 with
0.5 mg extract/mL shows crystal formation dominated by cal-
cium oxalate dihydrate crystals (640).
Fig. 3 The micrograph at a supersaturation of 20.0 with
1.0 mg extract/mL shows increased crystal formation domi-
nated by calcium oxalate dihydrate crystals (640).
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The effect of the extract on the morphology and nucleation
of the crystal were studied at various degrees of super-
saturation and extract levels. The degree of supersatura-
tion was varied from 10.0, 12.5, 15.0, 17.5, to 20.0. These
degrees of supersaturation are based on the solubility of
calcium oxalate monohydrate at 25 C calculated as:
SZ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½Ca2þ
h
C2O
2
4
i
Ksp; 25C
vuut
The concentration of calcium and oxalate was main-
tained at a 1:1 ratio since studies showed that changes in
their proportion also influence the morphology of the
crystals produced. Literature data for the solubility product
constant will be adopted i.e., Ksp,25 CZ 10
8.69 [16]. Thus
at a supersaturation of 10, the molarity of calcium chloride
and sodium oxalate are equivalent to a value of
0.4519 mmol/L.
The level of extract addition was limited to 3; the blank
0 mg/mL, 0.5 mg/mL and 1.0 mg/mL. This means of
expressing the concentration refers to the ratio of mass of
dried leaves used in the preparation of the decoction to the
final volume of the solution formed after the extract was
added to the crystallization solution.
3. Results and discussion
COM is primarily, if not solely formed across all degrees of
supersaturation whenever the extract is absent from the
crystallization solution as shown in Fig. 1. The COM crystals
are easily identified by their characteristic hexagonal
shape. In solutions without the extract, the crystals are also
limited in number but greater in size. Heterogeneous
growth is also observed at higher supersaturations. Figs. 2
and 3 show that in the presence of extract in theFig. 1 Micrograph at a supersaturation of 10.0 (a), 15.0 (b)
and 20.0 (c) with 0 mg extract/mL. A small number of calcium
oxalate monohydrate crystals are observed across all degrees
of supersaturation (160 and 640).
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calcium oxalate crystals, Asian Journal of Urology (2016), http://dx.dsolution, the size of crystals formed after 72 h are signifi-
cantly smaller than those formed in the absence of extract,
while the amount of crystals in the micrograph increases as
the size decrease. The square projection of the octahedral
COD crystals dominates these micrographs.
The micrographs were then subjected to image analysis
using the software ImageJ. Treatments such as adjustment
of brightness, contrast and conversion to the required
formatting were done on the micrographs until these were
suitable for image analysis and the particles could be
characterized in terms of their size and shape.
3.1. Crystal size
The size of the particles is reported as the Feret diameter
(dF) and equivalent circle diameter (deq). The particle size
distribution (PSD) of the crystals based on dF and deq are
determined. Figs. 4 and 5 show the particle size distribution
for a supersaturation level of 20 containing 0 mg of extract/
mL. As it is defined, dF is inherently greater than deq or
equal when the particle measured is a circle. The crystalst of Blumea balsamifera extract on the phase and morphology of
oi.org/10.1016/j.ajur.2016.08.009
Fig. 4 Feret diameter particle size distribution for a super-
saturation 20 without extract. The mode and median occurred
at 0.0075 mm (two-sample paired t-test, p < 0.075).
Fig. 5 Equivalent circle diameter particle size distribution
for a supersaturation 20 without extract. The mode and me-
dian occurred at 0.0075 mm similar to the Feret diameter
particle size distribution (two-sample paired t-test,
p < 0.075).
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AJUR126_proof ■ 9 September 2016 ■ 4/7of COM and COD have diagonals that are longer than the
equivalent circle diameter. The PSD for dF also covers a
wider range compared to that for the deq.
Presenting the particle diameter as dF or deq as an
arithmetic or area mean would result into four possible
ways of presenting the particle size. The arithmetic mean
and area mean of the Feret and equivalent circle diameters
are summarized in Fig. 6.Fig. 6 Mean diameters for various degrees of supersaturation
containing 0 mg extract/mL. Regardless of the method of
expressing the diameter, it generally decreases with increasing
supersaturation with a discontinuity between a supersaturation
of 12.5 and 15.0.
Please cite this article in press as: Montealegre CM, De Leon RL, Effec
calcium oxalate crystals, Asian Journal of Urology (2016), http://dx.dThe area mean diameters are consistently greater than
the arithmetic means due to the equal contribution of the
large and small particles to the mean diameter. Fig. 6 also
shows that the highest diameters were reported for area
mean dF, followed by arithmetic mean dF, area mean deq
and the least is for arithmetic mean deq. The relative
standard deviation across supersaturation levels are
23.24%e26.93% except for the supersaturation of 20 where
the relative standard deviation reached up to 46.54%.
Regardless of the method for presenting the mean, the
diameters and their combinations, the trends in the change
of the diameter with respect to the degree of saturation
are similar. Increasing the supersaturation decreases the
diameter of the crystal. This is true from a supersaturation
degree of 10e12.5 and 15e20 but a jump discontinuity is
observed between 12.5 and 15.
Upon the addition of B. balsamifera extract, the size of
the crystals are essentially constant across all degrees of
supersaturation and extract concentration with an area
mean Feret diameter of 9.63  0.76 mm corresponding to a
relative standard deviation of 7.84%.
The mean diameters changed dramatically ranging from
5.22% to 82.69% (depending on the type of mean and
diameter) with respect to the untreated systems as shown
in Fig. 7. The reduction in crystal size is highest at a su-
persaturation of 15.0 and on average, smallest at a super-
saturation of 12.5.
3.2. Crystal shape
The shape of the crystal is indicative of its type. Fig. 8
shows the typical projections observed from the micro-
graphs of the crystals. COM crystals are composed of
elongated rhombohedron units exhibiting a hexagonal pro-
jection along its 010 and 101 faces shown in Fig. 8a and b
respectively. COD crystals are octahedral with a square or
diamond shaped projection shown in Fig. 8c. These distinct
crystal morphologies are used as the primary means of
differentiating between the calcium oxalate hydrates.
Fig. 8d shows a short dumbbell-shaped projection of a
calcium oxalate trihydrate crystal. This morphology was
only observed once in this study.
Aspect ratio is used to differentiate between COM and
COD crystals. Crystals with an aspect ratio greater than 1.5
are classified as COM. To determine the relative abundanceFig. 7 Crystal size decreased drastically at 0.5 and 1.0 mg
extract/mL across all levels of supersaturation.
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Fig. 8 Micrographs of calcium oxalate crystals. (a) The 010 face of a calcium oxalate monohydrate crystal. (b) 101 face of calcium
oxalate monohydrate crystal. (c) Top view of the octahedral calcium oxalate dihydrate crystal. (d) Dumbell shaped cross section
characteristic of a calcium oxalate trihydrate crystal.
Fig. 10 A structure forming from aggregated crystals with a
high degree of branching and inter-crystal growth.
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AJUR126_proof ■ 9 September 2016 ■ 5/7of COM and COD crystals formed, the projected area of
crystals identified as COM is summed and its fraction to the
total projected area is calculated. Fig. 9 summarizes the
COM fractions at varying degrees of supersaturation and
extract levels.
Fig. 9 shows that COM crystals are predominantly pre-
sent at 0 mg of extract/mL. The presence of the extract at
0.5 mg/mL and 1.0 mg/mL dramatically shifted the
morphology of the crystals into the formation of COD. The
area fraction of COM crystals changed from an average of
0.9932  0.0122 without the extract to 0.1158  0.1287 and
0.08417  0.0928 at 0.5 and 1.0 mg extract/mL respec-
tively. This corresponds to an average COM area fraction
reduction of 88.26%  13.03% at 0.5 mg/mL and
91.53%  9.29% at 1.0 mg/mL. The high standard deviation
of the percent reduction implies that there is no significant
difference between an extract level of 0.5 or 1.0 mg/mL.
Various studies on growth modifiers reported a similar COM
to COD shift [5,7,16] but only in this study is this shift
quantified.
Some microscopy observations that are difficult to
quantify by the methods mentioned above, were not
included in the analysis. An example of such observation is
shown in Fig. 10. This was observed at a supersaturation of
17.5.
This could be explained by a high degree of heteroge-
neous nucleation that is out of the scope of this study. The
cross-shaped structure may be a result of over growth in the
(011) and (011) faces of COM. These were only observed at
supersaturation levels of 17.5 and 20 in the absence of the
extract. At these conditions it is possible that the crystal3
Fig. 9 Calcium oxalate monohydrate dominated the pro-
jected are fraction at 0 mg extract/mL. Presence of the
extract resulted into a decrease of calcium oxalate mono-
hydrate fraction suggesting a dominant formation of calcium
oxalate dihydrate crystals.
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calcium oxalate crystals, Asian Journal of Urology (2016), http://dx.dhabit is altered. The fact that highly aggregated structures
like those shown in Fig. 10 are only observed when the
extract is absent from the crystallization solution suggests
an inhibiting action of the extract towards aggregation and
the observed overgrowth.
3.3. Powder X-ray diffraction and scanning electron
microscopy
The crystals produced from a supersaturation of 20 were air
dried. The powder X-ray diffraction spectra show strong
peaks, indicating the crystalline nature of the samples.
Fig. 11 shows that at 0.1 mg extract/mL, the charac-
teristic peaks for COM [17] have the highest intensities.
However, at 1.0 mg extract/mL the intensities of the peaks
for COM are very low relative to stronger peaks at 2q po-
sitions 44.5, 64.8 and 77.86 indicating the (200) and (211)
faces of a tetragonal crystal [18]. The intensity of the
spectra supports the observation that at low extract con-
centrations COM crystals are predominantly formed and at
the highest extract concentration of 1.0 mg/mL, the peaks
for COM are observed but at a relatively very low intensity
compared with peaks related to the (200) face of a
tetragonal crystal which may indicate COD. A comparison
with the micrographs in Fig. 3 suggests that these strong
peaks may be attributed to COD.
Micrographs were taken using a Scanning Electron Mi-
croscope, shown in Fig. 12aec. Q
Fig. 12aec shows how the crystal morphology changed at
the highest degree of supersaturation 20. In Fig. 12at of Blumea balsamifera extract on the phase and morphology of
oi.org/10.1016/j.ajur.2016.08.009
Fig. 11 The powder X-ray diffraction spectra of samples at a
supersaturation of 20.0 and an extract level of 0.1 mg/mL (a),
and at 1.0 mg/mL (b) show strong peaks. Crossmarks refer to
characteristic peaks for calcium oxalate monohydrate [17].
Fig. 12 Scanning electron microscope micrograph a) for a super
boundaries. b) At a supersaturation 20.0 with 0.1 mg extract/mL d
boundaries were observed at a supersaturation 20.0 with 1.0 mg e
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calcium oxalate crystals, Asian Journal of Urology (2016), http://dx.dwithout the extract, it is difficult to discern the boundaries
between crystals suggesting heterogeneous growth result-
ing to merging of different crystal units. In Fig. 12b, a slight
addition of the extract at 0.1 mg/mL resulted into indi-
vidual crystal units that are discernible. Aggregation is
observed but a lot less than the former. Crystals in Fig. 12c
were grown at an extract concentration of 1.0 mg/mL. The
crystal units are separate, smaller and the shape is
discernible. Crystal shapes characteristic of the (010) and
(101) side of COM is evident. Majority of the crystal formed
also had a low aspect ratio evident from its square pro-
jection. These observations evidently support an earlier
claim made, i.e. B. balsamifera extract minimizes crystal
aggregation aside from modifying the morphology.
The results showed that B. balsamifera extract
decreased the crystal size, shifted the phase of the crystals
into COD and inhibited crystal aggregation. This may be the
effect of modification in the solution properties of the
crystallization medium brought about by the addition of
compounds, in this case phytochemicals in the B. balsa-
mifera extract. Such effects have been observed even at
very low concentrations [7]. A similar change in solution
property due to a plant extract was reported as the surface
free energy decreased due to Khella plant extract [5].
4. Conclusion
Micrographs taken at different levels of supersaturation and
extract concentration exhibited a marked difference in
terms of crystal size and shape. Analysis of the crystal sizesaturation 20.0 without the extract shows indiscernible crystal
iscernible crystal boundaries were observed. c) Distinct crystal
xtract/mL.
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showed that at 0.5 and 1.0 mg extract/mL, the size
decreased by 5.22%e82.69%, depending on the degree of
saturation. Crystals were classified as COM or COD
depending on the aspect ratio. It was found that the extract
reduced the projected area fraction of COM crystals from
an average of 0.9932  0.0122 to 0.1158  0.1287 at 0.5 mg
extract/mL and 0.08417  0.0928 1.0 mg extract/mL sug-
gesting a shift of crystal phase from COM to COD.
The extract decreased the crystal size, shifted the phase
of the crystals into COD and inhibited crystal aggregation.
This could be beneficial in the prevention of stone forma-
tion. Not only will the formed crystals be smaller, but the
implication that these crystals might have a lower likeli-
hood of aggregation shows that the crystals formed could
more easily be eliminated by natural means. This is very
beneficial for stone formers since studies suggest that the
biochemical pathways of a stone former will always pro-
mote stone formation but the presence of growth modifiers
such as phytochemicals found in B. balsamifera could aid in
the elimination of stone.
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